Novo Nordisk A/S Series B

Novo Nordisk upgraded to overweight from neutral at J.P. Morgan

6:44 a.m. June 7, 2022

- Tomi Kilgore

Lilly’s experimental obesity drug may be a ‘multibillion-dollar opportunity’

8:20 a.m. May 2, 2022

- Jaimy Lee

This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst

10:14 a.m. March 22, 2022

- Barbara Kollmeyer

European stocks advance after partial Russian troop withdrawal

9:55 a.m. Feb. 15, 2022

- Steve Goldstein

GlaxoSmithKline shares soar after Unilever bids for its consumer healthcare unit

7:56 a.m. Jan. 17, 2022

- Barbara Kollmeyer

European stocks inch closer to all-time high, inspired by Wall Street optimism

6:21 a.m. Dec. 28, 2021

- Barbara Kollmeyer

Germany is getting a new chancellor. Here’s how the DAX has performed under outgoing chancellor Angela Merkel.

12:19 p.m. Dec. 8, 2021

- Barbara Kollmeyer

Novo Nordisk strikes $3.3 billion deal to buy research partner Dicerna Pharmaceuticals

8:19 a.m. Nov. 18, 2021

- Steve Goldstein

European markets drift lower, as healthcare stocks retreat

8:10 a.m. Aug. 24, 2021

Bank of America downgrades U.K. stocks and reiterates overweight on Spain, Italy and Germany

8:56 a.m. Aug. 5, 2021

- Steve Goldstein

Prothena sells ATTR amyloidosis portfolio to Novo Nordisk for up to $1.2 billion

12:45 p.m. July 12, 2021

- Jaimy Lee

European stocks struggle at the end of the week

10:15 a.m. June 25, 2021

- Barbara Kollmeyer

European stocks gain, led by Adidas after upbeat results

10:55 a.m. March 10, 2021

- Barbara Kollmeyer

Banks slump in Europe as stocks lurch toward worst week since June

8:25 a.m. Sept. 25, 2020

- Barbara Kollmeyer

European stocks slip amid coronavirus vaccine doubts

9:04 a.m. May 20, 2020

- Barbara Kollmeyer

European stocks slip, as EU forecasts gloom and BMW slides on warning

11:07 a.m. May 6, 2020

- Barbara Kollmeyer

European stocks climb on hopes over coronavirus drug treatment

11:16 a.m. April 17, 2020

- Barbara Kollmeyer

Novo Nordisk downgraded by UBS on concerns over drug launch cost

6:19 a.m. Nov. 18, 2019

- Steve Goldstein

Novo Nordisk profit beats on strength in diabetes, obesity treatments

3:17 a.m. Nov. 1, 2019

- Dominic Chopping

Defensive plays nudge European stocks higher as key jobs data awaits

4:34 a.m. Oct. 4, 2019

- Steve Goldstein

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition